Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS
· Delayed Price · Currency is USD
0.0091
+0.0002 (2.25%)
Apr 28, 2026, 9:30 AM EST
Emmaus Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 2.13 | 1.39 | 2.55 | 2.02 | 2.28 | Upgrade
|
| Cash & Short-Term Investments | 2.13 | 1.39 | 2.55 | 2.02 | 2.28 | Upgrade
|
| Cash Growth | 53.13% | -45.47% | 26.03% | -11.32% | -8.36% | Upgrade
|
| Receivables | 2.8 | 2.62 | 5.52 | 0.38 | 1.04 | Upgrade
|
| Inventory | 1.56 | 1.64 | 1.71 | 2.38 | 4.39 | Upgrade
|
| Prepaid Expenses | 0.9 | 0.89 | 1.13 | 1.07 | 0.99 | Upgrade
|
| Other Current Assets | 0.36 | 0.23 | 0.6 | 0.45 | 0.39 | Upgrade
|
| Total Current Assets | 7.75 | 6.77 | 11.51 | 6.29 | 9.09 | Upgrade
|
| Property, Plant & Equipment | 0.88 | 1.58 | 2.4 | 2.87 | 3.63 | Upgrade
|
| Long-Term Investments | 12.6 | 15.04 | 20.98 | 38.8 | 43.72 | Upgrade
|
| Other Long-Term Assets | 0.21 | 0.22 | 0.3 | 0.26 | 0.3 | Upgrade
|
| Total Assets | 21.44 | 23.6 | 35.18 | 48.23 | 56.73 | Upgrade
|
| Accounts Payable | 0.28 | 0.59 | 0.52 | 0.3 | 0.26 | Upgrade
|
| Accrued Expenses | 25.52 | 21.33 | 18.59 | 14.45 | 8.93 | Upgrade
|
| Short-Term Debt | 11.15 | 10.47 | 11.34 | 9.18 | 3.6 | Upgrade
|
| Current Portion of Long-Term Debt | 17.38 | 17.01 | 16.38 | 14.66 | 10.16 | Upgrade
|
| Current Portion of Leases | 0.35 | 2.42 | 1.64 | 0.7 | 0.74 | Upgrade
|
| Current Unearned Revenue | 13 | 10 | 10 | 10 | - | Upgrade
|
| Other Current Liabilities | 1.39 | 1.73 | 3.04 | 5.04 | 13.41 | Upgrade
|
| Total Current Liabilities | 69.07 | 63.56 | 61.51 | 54.32 | 37.1 | Upgrade
|
| Long-Term Debt | 2.27 | 2.25 | 2.23 | 3.73 | 4.65 | Upgrade
|
| Long-Term Leases | 1.41 | 0.82 | 1.84 | 2.55 | 3.26 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 10 | Upgrade
|
| Other Long-Term Liabilities | 12.29 | 13.47 | 17.36 | 21.71 | 23.17 | Upgrade
|
| Total Liabilities | 85.04 | 80.08 | 82.94 | 82.32 | 78.18 | Upgrade
|
| Common Stock | 0.07 | 0.06 | 0.06 | 0.05 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 225.99 | 225.9 | 225.33 | 220.82 | 220.02 | Upgrade
|
| Retained Earnings | -270.07 | -262.58 | -256.12 | -252.34 | -241.27 | Upgrade
|
| Comprehensive Income & Other | -19.6 | -19.86 | -17.03 | -2.62 | -0.26 | Upgrade
|
| Shareholders' Equity | -63.61 | -56.48 | -47.76 | -34.09 | -21.45 | Upgrade
|
| Total Liabilities & Equity | 21.44 | 23.6 | 35.18 | 48.23 | 56.73 | Upgrade
|
| Total Debt | 32.56 | 32.96 | 33.42 | 30.82 | 22.41 | Upgrade
|
| Net Cash (Debt) | -30.43 | -31.57 | -30.88 | -28.8 | -20.13 | Upgrade
|
| Net Cash Per Share | -0.48 | -0.50 | -0.58 | -0.58 | -0.41 | Upgrade
|
| Filing Date Shares Outstanding | 70.19 | 63.87 | 61.85 | 50.93 | 49.31 | Upgrade
|
| Total Common Shares Outstanding | 70.19 | 63.87 | 61.85 | 49.58 | 49.31 | Upgrade
|
| Working Capital | -61.33 | -56.79 | -50 | -48.03 | -28.01 | Upgrade
|
| Book Value Per Share | -0.91 | -0.88 | -0.77 | -0.69 | -0.43 | Upgrade
|
| Tangible Book Value | -63.61 | -56.48 | -47.76 | -34.09 | -21.45 | Upgrade
|
| Tangible Book Value Per Share | -0.91 | -0.88 | -0.77 | -0.69 | -0.43 | Upgrade
|
| Machinery | 0.45 | 0.39 | 0.48 | 0.47 | 0.45 | Upgrade
|
| Construction In Progress | - | - | - | - | 0.06 | Upgrade
|
| Leasehold Improvements | 0.02 | 0.02 | 0.04 | 0.04 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.